Curis (CRIS) Operating Expenses (2010 - 2026)
Curis' (CRIS) quarterly Operating Expenses came in at $11.5 million in Q1 2026, down 8.12% YoY from $12.5 million in Q1 2025, and up 32.28% on a QoQ basis from $8.7 million in Q4 2025.
Curis (CRIS) Operating Expenses (2010 - 2026) Analysis & Trends
Curis (CRIS) has 17 years of Operating Expenses data on file, last reported at $11.5 million in Q1 2026.
- Quarterly Operating Expenses fell 8.12% year-over-year to $11.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $41.3 million (down 22.65% YoY) and the FY2025 annual result came in at $42.3 million, down 23.63% from the prior year.
- Operating Expenses grew to $11.5 million in Q1 2026, from $8.7 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $17.5 million in Q2 2022 to a low of $8.7 million in Q4 2025.
- A 5-year average of $13.6 million and a median of $13.9 million in 2023 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2022 — Operating Expenses soared 56.43% — and 2025, when it fell 29.43%.
- Tracing CRIS's Operating Expenses over 5 years: stood at $13.1 million in 2022, then climbed by 13.64% to $14.9 million in 2023, then dropped by 17.16% to $12.3 million in 2024, then fell by 29.43% to $8.7 million in 2025, then soared by 32.28% to $11.5 million in 2026.
- The last three Operating Expenses figures came in at $11.5 million (Q1 2026), $8.7 million (Q4 2025), and $10.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.06 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 427.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 541.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -784.57 Mn |
| 10 | Curis | 3.44 Mn | -2.18 Mn | - | 9.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.52 Mn |
| Dec 31, 2025 | 8.71 Mn |
| Sep 30, 2025 | 10.10 Mn |
| Jun 30, 2025 | 11.00 Mn |
| Mar 31, 2025 | 12.54 Mn |
| Dec 31, 2024 | 12.34 Mn |
| Sep 30, 2024 | 13.50 Mn |
| Jun 30, 2024 | 15.06 Mn |
| Mar 31, 2024 | 14.56 Mn |
| Dec 31, 2023 | 14.90 Mn |
| Sep 30, 2023 | 15.20 Mn |
| Jun 30, 2023 | 14.34 Mn |
| Mar 31, 2023 | 13.92 Mn |
| Dec 31, 2022 | 13.11 Mn |
| Sep 30, 2022 | 15.43 Mn |
| Jun 30, 2022 | 17.45 Mn |
| Mar 31, 2022 | 17.19 Mn |
| Dec 31, 2021 | 15.70 Mn |
| Sep 30, 2021 | 13.09 Mn |
| Jun 30, 2021 | 12.94 Mn |